Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (301-310 of 369) with videos related to

Pageof 37
Sort By:
Scientific Reports|March 24, 2023
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIVDavid M MacDonald, Sarah Samorodnitsky, Chris H Wendt, et al.
Southern African Journal of HIV Medicine|March 24, 2018
Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South AfricaAndrew Revell, Paul Khabo, Lotty Ledwaba, et al.
Plos Medicine|April 16, 2013
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studiesLeigh F Johnson, Joel Mossong, Rob E Dorrington, et al.
The Lancet. Infectious Diseases|February 13, 2016
The transmission of Mycobacterium tuberculosis in high burden settingsTom A Yates, Palwasha Y Khan, Gwenan M Knight, et al.
BMC Public Health|May 27, 2011
Asking the right questions: developing evidence-based strategies for treating HIV in women and childrenQuarraisha Abdool Karim, Anchilla Banegura, Pedro Cahn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2017
Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment OutcomesJulia K Rohr, Prudence Ive, Charles Robert Horsburgh, et al.
Plos One|January 28, 2014
Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectivenessIngrid V Bassett, Darshini Govindasamy, Alison S Erlwanger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2015
Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012Mireille Porter, Mary-Ann Davies, Muntanga K Mapani, et al.
Plos One|February 15, 2022
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven samplingTara Carney, Jennifer A Rooney, Nandi Niemand, et al.
The Lancet. HIV|October 2, 2015
Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysisMark A Boyd, Cecilia L Moore, Jean-Michel Molina, et al.
Pageof 37

Showing results (301-310 of 369) with videos related to

Sort By:
Pageof 37
Scientific Reports|March 24, 2023
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIVDavid M MacDonald, Sarah Samorodnitsky, Chris H Wendt, et al.
Southern African Journal of HIV Medicine|March 24, 2018
Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South AfricaAndrew Revell, Paul Khabo, Lotty Ledwaba, et al.
Plos Medicine|April 16, 2013
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studiesLeigh F Johnson, Joel Mossong, Rob E Dorrington, et al.
The Lancet. Infectious Diseases|February 13, 2016
The transmission of Mycobacterium tuberculosis in high burden settingsTom A Yates, Palwasha Y Khan, Gwenan M Knight, et al.
BMC Public Health|May 27, 2011
Asking the right questions: developing evidence-based strategies for treating HIV in women and childrenQuarraisha Abdool Karim, Anchilla Banegura, Pedro Cahn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2017
Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment OutcomesJulia K Rohr, Prudence Ive, Charles Robert Horsburgh, et al.
Plos One|January 28, 2014
Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectivenessIngrid V Bassett, Darshini Govindasamy, Alison S Erlwanger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2015
Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012Mireille Porter, Mary-Ann Davies, Muntanga K Mapani, et al.
Plos One|February 15, 2022
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven samplingTara Carney, Jennifer A Rooney, Nandi Niemand, et al.
The Lancet. HIV|October 2, 2015
Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysisMark A Boyd, Cecilia L Moore, Jean-Michel Molina, et al.
Pageof 37